Osteoporosis--pathogenesis, prevention, therapy
Dambacher, M.A.; Ittner, J.; Rüegsegger, P.
Der Internist 27(3): 206-213
1986
ISSN/ISBN: 0020-9554 PMID: 3519506 Document Number: 280136
Document emailed within 1 workday
Related Documents
Prelević, G.M. 1991: Postmenopausal osteoporosis--definition, pathogenesis, prevention and therapy Srpski Arhiv Za Celokupno Lekarstvo 119(5-6): 155-161Ciammella, M.; Guareschi, B.; Pes, S.; Cocucci, C.; Nencioni, T. 1993: Substitution estrogen therapy in the prevention of postmenopausal osteoporosis and cardiovascular diseases. Results of long-term therapy Minerva Ginecologica 45(1-2): 53-55
Kruse, H.P. 1999: The prevention and therapy of steroid-induced osteoporosis Deutsche Medizinische Wochenschrift 124(50): 1538
Stĕpán, J. 1995: Significance of gestagens in the prevention and therapy of postmenopausal osteoporosis Ceska Gynekologie 60(5): 237-239
Lamy, O.; Krieg, M-Antoine. 2002: Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis Revue Medicale de la Suisse Romande 122(8): 377-381
Zylberberg, B.; Dormont, D. 1996: Biweekly menopausal substitutive hormone therapy: effects on climacteric and prevention of osteoporosis Contraception Fertilite Sexualite 24(12): 874-878
Arnanz Velasco, F.; Andreu Sánchez, J.L. 2004: Controversies and facts about the hormonal replacement therapy for prevention of osteoporosis in postmenopausal women Revista Clinica Espanola 204(2): 101-102
Jolles, B.M.; Bogoch, E.R. 2002: Current consensus recommendations for rheumatoid arthritis therapy: a blind spot for osteoporosis prevention and treatment Journal of Rheumatology 29(9): 1814-1817
Niedner, R. 1989: Sunburn. Irradiation, pathogenesis, therapy, prevention Medizinische Monatsschrift für Pharmazeuten 12(5): 141-146
Segal, E. 1999: Experimental candidosis. Pathogenesis, prevention, therapy Mycoses 42 Suppl. 2: 55-59
Shostak, N.A.; Muradiants, A.A.; Kondrashov, A.A.; Denisova, S.N. 2014: Clinical efficacy instant goat milk in the complex therapy and prevention of osteoporosis in patients with rheumatoid arthritis Voprosy Pitaniia 83(5): 79-85
Seiler, W.O.; Stähelin, H.B. 1991: Decubitus ulcers in geriatrics--pathogenesis, prevention and therapy Therapeutische Umschau. Revue Therapeutique 48(5): 329-340
Pár, A. 1992: Pathogenesis, therapy, prevention and prognosis in chronic viral hepatitis Orvosi Hetilap 133 Suppl. 1: 51-63
Gheorghiu, T. 1995: Gastroduodenal stress lesions and hemorrhages--pathogenesis, diagnosis, prevention and therapy Zentralblatt für Chirurgie 120(9): 670-676
Marshall, M. 1982: Thrombocyte function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 1. Pathogenesis, prevention, therapy Fortschritte der Medizin 100(14): 650-655
Orimo, H.; Kanaki, M. 1990: Pathogenesis of involutional osteoporosis Nihon Rinsho. Japanese Journal of Clinical Medicine 48(12): 2726-2728
Heidelmann, G. 1979: Problems of high-dose sodium fluoride therapy in osteoporosis. 3. Practice of osteoporosis therapy with sodium fluoride Zeitschrift für Arztliche Fortbildung 73(12): 581-584
Giouleme, O.I.; Vyzantiadis, T.A.; Nikolaidis, N.L.; Vasiliadis, T.G.; Papageorgiou, A.A.; Eugenidis, N.P.; Harsoulis, F.I. 2006: Pathogenesis of osteoporosis in liver cirrhosis Hepato-Gastroenterology 53(72): 938-943
Gallagher, J.C. 1996: The role of vitamin D in the pathogenesis and treatment of osteoporosis Journal of Rheumatology. Suppl 45: 15-18
Scharla, S.H. 1999: Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis MMW Fortschritte der Medizin 141(31-32): 32-36